New radiation technique could boost immunotherapy in advanced lung cancer
NCT ID NCT06660407
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase II trial at Mayo Clinic is testing a special type of radiation called grid therapy combined with standard immunotherapy for people with stage IV non-small cell lung cancer that has stopped responding to treatment. Grid therapy delivers high doses of radiation to small areas of the tumor, which may help kill cancer cells more effectively. The study will enroll 20 adults to see if this combination is safe and can shrink tumors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- grid radiation therapy
- What this could lead to
- If it works, this could offer a new treatment option for advanced lung cancer patients whose disease has worsened despite immunotherapy.
- What could go wrong
- This is a small early-phase trial with only 20 participants, so results may not apply broadly. There is also a risk of serious side effects from the radiation and immunotherapy combination.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Facing the fear: a new program aims to ease anxiety in advanced cancer
- Can a Chemo-Immunotherapy duo outsmart tough lung cancer?
- Could a simple assessment help older lung cancer patients tolerate chemo better?
- Wheat germ supplement studied for immune boost in advanced cancer
- New imaging agent may help doctors see which lung tumors are still growing during immunotherapy
- New drug combo shows promise for tough cancers